Economy · World
Sun Pharma Secures US Deal for Cheaper Medicines, Tariff Delay
Sun Pharmaceutical Industries has entered into an agreement with the U.S. government to supply lower-cost medicines, potentially impacting Medicaid drug prices. The deal also includes a delay in tariffs. This agreement aims to make essential medications more affordable for American consumers. Further details on the specific drugs and the duration of the tariff delay were not immediately available in the coverage.
How outlets across the spectrum covered it
L 0 C 3 R 0
- Centre (3): Business Today, Hindustan Times, Outlook India